Following the announcement of a study into the long-term effects of weight loss medications, UK Active and CIMSPA have issued ...

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down substance use cravings too.

The Health Secretary has said offering weight loss jabs to unemployed obese people is not “dystopian”. Wes Streeting said a trial to test if anti-obesity injections can increase employment and ease ...

The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...

To make $1 million in the stock market, you don't need to invest a fortune. But you'll definitely want to take the time to ...

Bad actors are using online ads, social media and bootleg ingredients to sell fake, inaccurate and harmful versions of these ...

New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.

Discover why Sagimet Biosciences' Denifanstat is a top contender in treating MASH, with FDA designation and strong financials ...

The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...

Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...

Millions of Americans rely on a new class of medications to manage chronic conditions like diabetes and obesity, with ...

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...